AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 278 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $108,951 | -25.1% | 10,983 | -16.3% | 0.04% | -49.4% |
| Q1 2023 | $145,523 | +19.3% | 13,122 | +3.8% | 0.09% | +93.5% |
| Q2 2021 | $122,000 | -57.9% | 12,641 | -57.0% | 0.05% | -48.9% |
| Q1 2021 | $290,000 | -23.1% | 29,380 | +79.8% | 0.09% | -30.2% |
| Q4 2020 | $377,000 | – | 16,340 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 9,029,843 | $89,576,043 | 10.38% |
| Perceptive Advisors | 28,057,456 | $278,329,964 | 6.70% |
| Redmile Group, LLC | 10,595,089 | $105,103,283 | 6.36% |
| STEMPOINT CAPITAL LP | 1,495,047 | $14,830,866 | 4.36% |
| CM Management, LLC | 450,000 | $4,464,000 | 4.10% |
| Avoro Capital Advisors LLC | 27,400,000 | $271,808,000 | 3.62% |
| GREAT POINT PARTNERS LLC | 1,495,500 | $14,835,360 | 2.84% |
| Saturn V Capital Management LP | 713,536 | $7,078,277 | 2.68% |
| AlphaCentric Advisors LLC | 202,500 | $2,008,800 | 1.48% |
| Novo Holdings A/S | 2,500,000 | $24,800,000 | 1.44% |